Advisors Asset Management Inc. Acquires 45,913 Shares of BlackRock Capital Allocation Term Trust $BCAT

Advisors Asset Management Inc. boosted its holdings in BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report) by 15.6% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 339,332 shares of the company’s stock after purchasing an additional 45,913 shares during the quarter. Advisors Asset Management Inc. owned 0.32% of BlackRock Capital Allocation Term Trust worth $5,019,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Royal Bank of Canada raised its position in shares of BlackRock Capital Allocation Term Trust by 401.7% in the first quarter. Royal Bank of Canada now owns 428,585 shares of the company’s stock valued at $6,172,000 after buying an additional 343,154 shares in the last quarter. Integrated Wealth Concepts LLC grew its position in BlackRock Capital Allocation Term Trust by 35.7% during the first quarter. Integrated Wealth Concepts LLC now owns 34,000 shares of the company’s stock worth $490,000 after buying an additional 8,950 shares in the last quarter. CWM LLC increased its stake in BlackRock Capital Allocation Term Trust by 8,947.4% during the 2nd quarter. CWM LLC now owns 70,479 shares of the company’s stock worth $1,067,000 after acquiring an additional 69,700 shares during the period. Joseph P. Lucia & Associates LLC raised its holdings in BlackRock Capital Allocation Term Trust by 37.2% in the 2nd quarter. Joseph P. Lucia & Associates LLC now owns 33,066 shares of the company’s stock valued at $501,000 after acquiring an additional 8,972 shares in the last quarter. Finally, Amplius Wealth Advisors LLC lifted its position in shares of BlackRock Capital Allocation Term Trust by 5.4% during the 2nd quarter. Amplius Wealth Advisors LLC now owns 30,576 shares of the company’s stock valued at $463,000 after acquiring an additional 1,571 shares during the period. Institutional investors and hedge funds own 36.12% of the company’s stock.

BlackRock Capital Allocation Term Trust Price Performance

BCAT opened at $15.14 on Friday. BlackRock Capital Allocation Term Trust has a 52-week low of $12.91 and a 52-week high of $15.91. The business’s fifty day moving average is $14.53 and its 200-day moving average is $14.65.

BlackRock Capital Allocation Term Trust Dividend Announcement

The company also recently announced a monthly dividend, which will be paid on Tuesday, March 31st. Shareholders of record on Friday, March 13th will be issued a $0.2607 dividend. This represents a c) annualized dividend and a yield of 20.7%. The ex-dividend date of this dividend is Friday, March 13th.

BlackRock Capital Allocation Term Trust Profile

(Free Report)

BlackRock Capital Allocation Term Trust (NYSE: BCAT) is a closed-end, diversified management investment company organized as a term trust. The fund’s primary objective is to deliver high current income and total return by investing across a broad range of credit and equity markets. BCAT seeks to achieve this objective through a portfolio of corporate debt securities, floating-rate loans, convertible securities, common and preferred equity, and asset-backed securities.

BCAT employs an actively managed, multi-sector credit approach that spans investment-grade and below-investment-grade bonds, senior secured loans and structured credit.

See Also

Want to see what other hedge funds are holding BCAT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for BlackRock Capital Allocation Term Trust (NYSE:BCATFree Report).

Institutional Ownership by Quarter for BlackRock Capital Allocation Term Trust (NYSE:BCAT)

Receive News & Ratings for BlackRock Capital Allocation Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Capital Allocation Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.